Ironwood Pharmaceuticals, Inc. (FRA:I76)

Ironwood Pharmaceuticals Statistics

Total Valuation

FRA:I76 has a market cap or net worth of EUR 489.78 million. The enterprise value is 883.60 million.

Market Cap	489.78M
Enterprise Value	883.60M

Important Dates

The next estimated earnings date is Friday, February 13, 2026.

Earnings Date	Feb 13, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	162.68M
Shares Outstanding	n/a
Shares Change (YoY)	+9.90%
Shares Change (QoQ)	+0.52%
Owned by Insiders (%)	2.38%
Owned by Institutions (%)	67.54%
Float	118.38M

Valuation Ratios

The trailing PE ratio is 20.13 and the forward PE ratio is 6.46.

PE Ratio	20.13
Forward PE	6.46
PS Ratio	1.70
PB Ratio	-2.18
P/TBV Ratio	n/a
P/FCF Ratio	8.49
P/OCF Ratio	8.49
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.90, with an EV/FCF ratio of 15.33.

EV / Earnings	36.31
EV / Sales	3.03
EV / EBITDA	6.90
EV / EBIT	7.14
EV / FCF	15.33

Financial Position

The company has a current ratio of 1.13

Current Ratio	1.13
Quick Ratio	1.08
Debt / Equity	n/a
Debt / EBITDA	4.02
Debt / FCF	8.84
Interest Coverage	4.26

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	22.88%
Return on Invested Capital (ROIC)	28.18%
Return on Capital Employed (ROCE)	93.63%
Revenue Per Employee	1.14M
Profits Per Employee	96,175
Employee Count	253
Asset Turnover	0.86
Inventory Turnover	n/a

Taxes

In the past 12 months, FRA:I76 has paid 55.41 million in taxes.

Income Tax	55.41M
Effective Tax Rate	69.49%

Stock Price Statistics

The stock price has decreased by -3.03% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-3.03%
50-Day Moving Average	1.78
200-Day Moving Average	1.12
Relative Strength Index (RSI)	72.88
Average Volume (20 Days)	895

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.44

Income Statement

In the last 12 months, FRA:I76 had revenue of EUR 288.92 million and earned 24.33 million in profits. Earnings per share was 0.15.

Revenue	288.92M
Gross Profit	293.35M
Operating Income	122.54M
Pretax Income	79.75M
Net Income	24.33M
EBITDA	124.16M
EBIT	122.54M
Earnings Per Share (EPS)	0.15

Balance Sheet

The company has 119.67 million in cash and 509.88 million in debt, giving a net cash position of -390.21 million.

Cash & Cash Equivalents	119.67M
Total Debt	509.88M
Net Cash	-390.21M
Net Cash Per Share	n/a
Equity (Book Value)	-225.14M
Book Value Per Share	-1.38
Working Capital	26.71M

Cash Flow

In the last 12 months, operating cash flow was 57.69 million and capital expenditures -29,831, giving a free cash flow of 57.66 million.

Operating Cash Flow	57.69M
Capital Expenditures	-29,831
Free Cash Flow	57.66M
FCF Per Share	n/a

Margins

Gross margin is 101.54%, with operating and profit margins of 42.41% and 8.42%.

Gross Margin	101.54%
Operating Margin	42.41%
Pretax Margin	27.60%
Profit Margin	8.42%
EBITDA Margin	42.97%
EBIT Margin	42.41%
FCF Margin	19.96%

Dividends & Yields

FRA:I76 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.90%
Shareholder Yield	-9.90%
Earnings Yield	4.97%
FCF Yield	11.77%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:I76 has an Altman Z-Score of -3.46 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.46
Piotroski F-Score	7